Mr. Davidson has been investing in early stage companies for over 18 years.
He is a managing partner of Labrador Ventures a California-based early stage technology venture fund.
Prior to Labrador, Mr. Davidson founded and served as CEO of Combion, Inc., which was acquired by Incyte (Nasdaq:INCY). He served previously as President of Alkermes, Inc. (NASDAQ: ALKS), a biotechnology company focused on drug delivery. Mr. Davidson also worked for MCI Communications and for Warner Communications.
He is a trustee of Phalarope Foundation, which focuses on enterprise development, and Woodcock Foundation. He serves on the boards of Acumen Fund, REDF and Rockefeller Philanthropy Advisors and is an advisory director of the Cancer Research Institute
Mr. Davidson is a graduate of Harvard College and Harvard Business School.
